A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167
COR1167-102
Phase 1 other active
Quick answer
A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167 for Chronic Heart Failure is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Chronic Heart Failure
- Phase
- Phase 1
- Modality
- other
- Status
- active